SAGILITY LIMITED (SAGILITY) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹44.7 (+1.82% day change)
Key ratios
- P/E ratio
- 22.58
- P/B ratio
- 1.93
- ROE (%)
- 9.57
- ROCE (%)
- 11.89
- Debt/Equity
- 0.11
- Dividend yield (%)
- 0.13
- Market cap (₹ Cr)
- 20,925.54
Forensic checks
Piotroski F-Score: 8/9 · Altman Z-Score: 7.92 · Beneish M-Score: -2.29
InvestSights quality score
82.3/100 — High Quality (descriptive data-driven composite; not a recommendation)
Management guidance track record
- Revenue growth including BroadPath: guided 20%, delivered 29.14% (FY26) — exceeded guidance
- Adjusted EBITDA margin: guided 25%, delivered 25.3% (FY26) — exceeded guidance
Latest earnings call (Q2 FY27)
AI summary: The most important signal was the combination of sustained organic growth and a margin-guidance upgrade despite weaker expected enrolment-season revenue and statutory wage increases. Q2 organic revenue growth remained 11.9% in constant currency, while adjusted EBITDA margin reached 26.3%, the “highest in six quarters.” This gave management confidence to raise FY27 adjusted…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.